Preclinical Antitumor Activity and Toxicity of the PSMA-Docetaxel Conjugate Substance in Comparison with Docetaxel In Vivo

Authors
Shchepin N.A. 1 , Machulkin A.E. 2 , Majouga A.G. 2 , Smirnova G.B. , Borisova Y.A. , Pokrovsky V.S. 1
Publisher
РУДН
Language
English
Pages
227-228
State
Published
Year
2021
Organizations
  • 1 RUDN University
  • 2 M.V. Lomonosov Moscow State University
  • 3 N.N. Blokhin Cancer Research Center
Keywords
Prostatic neoplasms; prostate-specific membrane antigen; docetaxel; conjugates
Share

Other records